Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Evidence of efficacy and safety data support the potential for vatiquinone to fill the significant unmet need for patients ...

Prasinezumab continues to be well tolerated and no new safety signals were observed.

Adicet Bio Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies ...

Partnership leverages PHICS technology to bring together a kinase and target of interest to modulate protein function.

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers. As use of outsourcing increases, more companies see it as strategic, and relationships with service ...

LGM Pharma’s chief executive talks industry trends and the company’s continued growth as a provider of tailored API and CDMO services. Contract Pharma is the premier media outlet linking contract ...

Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

The characterization of product-related variants in monoclonal antibodies involves identifying and quantifying the size and charge of variants that can impact.. In biotherapeutics manufacturing, ...

Overcoming distribution hurdles to meet demand, cold chain solutions and strategies, and streamlining the supply chain to mitigate rising costs. Unique capabilities needed to overcome obstacles for ...